What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Jürgen Finke focuses on Transplantation, Internal medicine, Surgery, Gastroenterology and Hematopoietic stem cell transplantation.
His studies in Transplantation integrate themes in fields like Haematopoiesis, Survival analysis, Immunology and Hazard ratio.
His Internal medicine study deals with Oncology intersecting with Risk factor and Donor lymphocyte infusion.
His Surgery study frequently draws parallels with other fields, such as Cumulative incidence.
His Gastroenterology research is multidisciplinary, relying on both Lomustine, Methotrexate, Neutropenia, Procarbazine and Acute lymphocytic leukemia.
His studies deal with areas such as Clinical trial, Targeted therapy, Cytopenia, Caspase 1 and Transplantation Conditioning as well as Hematopoietic stem cell transplantation.
His most cited work include:
- Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia (986 citations)
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial (470 citations)
- Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). (379 citations)
What are the main themes of his work throughout his whole career to date?
Jürgen Finke mainly focuses on Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Oncology.
His work on Internal medicine is being expanded to include thematically relevant topics such as Gastroenterology.
His Transplantation research is multidisciplinary, incorporating elements of Leukemia, Myeloid leukemia, Immunology and Stem cell.
Jürgen Finke combines topics linked to Incidence with his work on Surgery.
The study incorporates disciplines such as Cancer, Regimen, Myelodysplastic syndromes, Transplantation Conditioning and Survival analysis in addition to Hematopoietic stem cell transplantation.
His Oncology research incorporates themes from Chronic lymphocytic leukemia and Lymphoma.
He most often published in these fields:
- Internal medicine (67.41%)
- Transplantation (65.37%)
- Surgery (33.15%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (67.41%)
- Transplantation (65.37%)
- Oncology (30.93%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Stem cell.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology.
Jürgen Finke studies Graft-versus-host disease which is a part of Transplantation.
His work in Oncology addresses subjects such as Cohort, which are connected to disciplines such as Myelofibrosis.
In his research on the topic of Hematopoietic stem cell transplantation, Transplantation Conditioning is strongly related with Myelodysplastic syndromes.
His Stem cell research includes themes of Hematology and Immunology.
Between 2016 and 2021, his most popular works were:
- Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel (133 citations)
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (99 citations)
- Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation (79 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Oncology and Leukemia.
His research integrates issues of Myeloid leukemia, Stem cell, Bone marrow and Disease in his study of Transplantation.
His work in Bone marrow covers topics such as Gastroenterology which are related to areas like Incidence.
Within one scientific family, Jürgen Finke focuses on topics pertaining to Surgery under Internal medicine, and may sometimes address concerns connected to Confidence interval.
Jürgen Finke interconnects Survival rate, Myelofibrosis, Transplantation Conditioning and Myelodysplastic syndromes in the investigation of issues within Hematopoietic stem cell transplantation.
While the research belongs to areas of Leukemia, Jürgen Finke spends his time largely on the problem of Myeloid, intersecting his research to questions surrounding Cyclophosphamide, T cell, Antigen presentation and Janus kinase 2.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
